Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Amwill Healthcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Amwill Healthcare IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 8.04 and post-issue EPS of ₹ 6.27 for FY24. The pre-issue P/E ratio is 13.81x, while the post-issue P/E ratio is 17.71x against the Industry P/E ratio is 36x. The company's ROCE for FY24 is 94.16%, ROE for FY24 is 73.06% and RoNW 73.06%. The Annualised EPS based on the latest financial data is ₹ 8.36 and PE ratio is 13.27x. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹8.04 |
| EPS Post IPO (Rs.) | ₹6.27 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 13.81 |
| P/E Post IPO | 17.71 |
| Adjusted 12M P/E Post IPO | |
| ROE | 73.06% |
| ROCE | 94.16% |
| P/BV | 3.06 |
| Debt/Equity | 0.01 |
| RoNW | 73.06% |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
